Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Vaccinations against viral respiratory infections
Influenza, Covid-19 and RSV – Update 2025
- GLP1-RA therapy
Improvement in either weight or HbA1c – but never both
- Suicide
Dealing with trauma after suicide loss: What do bereaved people experience as effective?
- COPD exacerbations
Fast therapy initiation is not much better than expected
- Galenic systems
Advantages of topical pharmacotherapy – Update 2025
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Psychedelics and related drug classes
Ritual, party or new therapy? Psychedelics and more: clinically illuminated
- Acute sinusitis: real-world study on first-line therapy